Therefore, IL-1β, CCL2, and CCL3 may be useful biomarkers for tracking infection and determining when antibiotic treatment could be terminated as well as for diagnosis, although additional studies are needed to validate this possibility. The gene discussed is CCL3; the disease is infection.